• FDA Breakthrough Device designation (bioelectronic application)
• First-in-human trial initiated (Pilot Study - Customer)
• Full QMS implementation (ISO 13485 compliant)
• Expansion of fabrication capabilities
• Broadened technology platform
• Achieved first market entry
• Team grew to 20 employees